Cerezyme fda label?

What does the FDA label for Cerezyme cover?

Cerezyme (imiglucerase) is an FDA-approved prescription medicine for Gaucher disease. The FDA label describes the approved uses, dosing, route of administration, and key safety information, including risks and monitoring guidance [1].

What is Cerezyme approved to treat?

The FDA label states Cerezyme is indicated for the treatment of Gaucher disease, including in patients who require enzyme replacement therapy [1].

How is Cerezyme dosed according to the label?

The label provides dosing instructions based on the patient population and clinical goals for Gaucher disease, including how it is administered and any dosing adjustments described by FDA-approved labeling [1].

What important safety warnings are on the Cerezyme label?

The FDA label includes safety information such as hypersensitivity-related reactions and other adverse reactions seen with imiglucerase, along with guidance on what to do if reactions occur [1].

Where can you find the exact “Cerezyme” FDA labeling language?

You can access the full prescribing information (FDA label) for Cerezyme through the FDA’s official drug labeling resources [1].

Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/ (Search for “Cerezyme” and open “Label” / “Prescribing Information”)